Headline
The latest stories from AHA Today.
Senate Republican leaders released a roughly $500 billion COVID-19 relief package that would provide additional assistance for priorities, including small businesses, enhanced unemployment insurance, child care, COVID-19 testing and schools.
The Centers for Medicare & Medicaid Services released the preliminary calendar 2019 unaudited occupational mix survey data, which will be used in area wage index calculations beginning in fiscal year 2022.
The AHA urged the National Academies of Sciences, Engineering and Medicine to adopt a unified set of guidelines to account for the variables associated with all issues of the eventual allocation of COVID-19 vaccine allocation.
The Centers for Medicare & Medicaid Services issued a final rule for the long-term care hospital prospective payment system for fiscal year 2021. Under the rule, net payments for LTCHs will decrease by 1.1% (-$40 million) relative to FY 2020 payments.
The Centers for Medicare & Medicaid Services issued a final rule that will increase Medicare inpatient prospective payment system rates by a net 2.9% in fiscal year 2021, compared to FY 2020, for hospitals that are meaningful users of electronic health records and submit quality measure data.
The AHA, joined by the Association of American Medical Colleges and several member hospitals, asked the full U.S. Court of Appeals for the District of Columbia Circuit to rehear a July 17 decision by a three-judge panel that upheld the authority of the Department of Health and Human Services to…
The AHA yesterday urged President Trump and the Department of Health and Human Services to continue to act on behalf of rural hospitals and health systems to address rural health care concerns. In a letter to the president, AHA recommended steps that support rural hospitals that are facing dire…
The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19.
The Food and Drug Administration further expanded the authorized use of remdesivir for treating COVID-19 patients, the agency announced. Now, remdesivir can be used for all admitted COVID-19 patients, confirmed or suspected, whether on oxygen, off oxygen or intubated.
Two new case studies highlight how hospitals and health systems are customizing care for older adult patients.